Trial
NCT01917318
Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
Novartis Pharmaceuticals
Condition
Post Traumatic Stress Disorder
Intervention
Iloperidone
Why stopped
Enrollment challenges - Single participant discontinued after placebo, no relevant outcome measure data was recorded.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-11